vimarsana.com

Latest Breaking News On - Kyowa hakko europe - Page 1 : vimarsana.com

NutraIngredients Awards 2024 Winners announced!

Comple med Launches the First Food Supplement in Europe Featuring IMMUSE®

Milan, Italy (PRWEB) February 01, 2023 Comple.med, an Italian based company engaged in the field of Complementary Medicines with an emphasis on

NutraIngredients Award Winners Europe 2022, Announced Earlier This Month

Dusseldorf, Germany (PRWEB) May 31, 2022 Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this

IMMUSE® Enters European Market Strengthen Your Body s Defenses from the Inside with IMMUSE®

IMMUSE® Enters European Market Strengthen Your Body’s Defenses from the Inside with IMMUSE® Share Article IMMUSE It is a truly unique strain of Lactococcus lactis which activates a broad range of immune cells in our body through the primary activation of pDC cells. This mechanism of action differentiates IMMUSE® from more conventional lactic acid bacteria or other immune ingredients” DUSSELDORF, Germany (PRWEB) April 20, 2021 Researchers at Kirin Holdings, Company Limited, a major Japanese brewing company and a fermentation leader for more than 130 years have found the Lactococcus lactis strain Plasma bacterium and demonstrated its unique ability to stimulate pDC (plasmacytoid dendritic cells), the “commander-in-chief” of the immune system that spurs other immune cells into action.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.